SomnusNooze e-newsletter
News, stories and updates from the world of sleep
SomnusNooze topics: Treatments
In Case You Missed It! – January 2019
Happy 2019! As we welcome the new year, we at the Hypersomnia Foundation have resolved to make things easier for our followers! In this month’s “In Case You Missed It!,” we highlight some of the most important news and social media posts about the... read >
In Case You Missed It! – December 2018
As the end of 2018 draws near, we know that your family and other social obligations can take over your life. So the Hypersomnia Foundation is here to make things easier and more joyful! In this month’s “In Case You Missed It!,” we highlight some of... read >
In Case You Missed It! – November 2018
As the holidays draw near, we know that life can get more hectic. So we’re here to make your life less stressful and more thankful! In this month’s “In Case You Missed It!,” we highlight some of the most important news and social media posts about... read >
In Case You Missed It! – August 2018
This new series highlights topics relating to sleep disorders that have been in the news and/or in our recent social media posts. Check here each month to make sure that you are up-to-date on the news relating to idiopathic hypersomnia and related sleep... read >
FAQs About Flumazenil Access
The Hypersomnia Foundation frequently receives questions about the use of flumazenil in treating idiopathic hypersomnia (IH) and related disorders. Most of the emails we receive ask how and where to find this medication. In response, we have researched... read >
Umecrine Cognition Expands Study of New Medicine GR3027 to IH
Everyone here at the Hypersomnia Foundation is always excited when researchers and pharmaceutical companies include IH as a part of their clinical trials and research. With each clinical trial and research project, we grow ever closer to more effective... read >
WEP Clinical – Expanded Access to Medications Not Yet Approved for General Prescription
October 2019 Addendum SEE ALSO: Global Genes RARE Toolkits Access to Unapproved Medicine: Is This an Option for Me? (USA) Access to Unapproved Medicine: Is This an Option for Me? (Canada) Do you and your healthcare provider feel you... read >
Arise Clinical Trial
CLINICAL TRIAL ENROLLING PATIENTS WITH IDIOPATHIC HYPERSOMNIA AND NARCOLEPSY TYPE 2 Balance Therapeutics is evaluating an investigational new drug BTD-001, to treat excessive daytime sleepiness in individuals diagnosed with idiopathic hypersomnia... read >
Dental Side Effects of Stimulants
Caring for Your Dental Health Did you know? Some stimulants can have dental side effects. by Sheri Katz, DDS, Diplomate, American Board of Dental Sleep Medicine Stimulants are often prescribed for the treatment of hypersomnias because they act to target... read >
Dental Side Effects of Stimulants for Treatment of Hypersomnias
Caring for Your Dental Health Did you know? Stimulants such as Adderall, Vyvanse, and Ritalin used for the treatment of hypersomnia, can have dental side effects. by Sheri Katz, DDS, Diplomate, American Board of Dental Sleep Medicine Stimulants are... read >